Astellas Pharma Inc: Psoriasis trials

The registry lists 15 Psoriasis studies with Astellas Pharma Inc as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 2 3Phase 3 6Phase 4 3No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis SubjectsCompletedNCT00658606Phase 4Results posted
• A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT01585233Phase 2
• A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe PsoriasisCompletedNCT01096862Phase 2
• Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe PsoriasisCompletedNCT00808223Phase 2
• Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque PsoriasisTerminatedNCT00795353
• Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque PsoriasisCompletedNCT00692172Phase 3
• A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00674063Phase 3
• A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or InappropriateCompletedNCT00673556Phase 3
• Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque PsoriasisCompletedNCT00493324Phase 4
• Assessment and Tracking of Long-term Alefacept SafetyTerminatedNCT00454701
• Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) ProgramCompletedNCT00371774
• A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293930Phase 3
• A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293917Phase 3
• A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293891Phase 3
• Community Based Trial for AMEVIVE®CompletedNCT00168753Phase 4